SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000891293-21-000008
Filing Date
2021-03-17
Accepted
2021-03-17 17:22:23
Documents
89
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 10-K ctic-20201231.htm   iXBRL 10-K 1609664
2 EX-4.5 a2020ex45descriptionofsecu.htm EX-4.5 11526
3 EX-10.29 a2020ex1029optionagreement.htm EX-10.29 77682
4 EX-23.1 a2020ex231accountingfirmco.htm EX-23.1 4239
5 EX-31.1 a2020ex311sect302certceo.htm EX-31.1 9968
6 EX-31.2 a2020ex312sect302certcfo.htm EX-31.2 10084
7 EX-32 a2020ex32sect906certceocfo.htm EX-32 7622
13 ctic-20201231_g1.jpg GRAPHIC 119045
  Complete submission text file 0000891293-21-000008.txt   8041485

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ctic-20201231.xsd EX-101.SCH 55542
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ctic-20201231_cal.xml EX-101.CAL 115026
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ctic-20201231_def.xml EX-101.DEF 314385
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ctic-20201231_lab.xml EX-101.LAB 721980
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ctic-20201231_pre.xml EX-101.PRE 475375
14 EXTRACTED XBRL INSTANCE DOCUMENT ctic-20201231_htm.xml XML 1070162
Mailing Address 3101 WESTERN AVENUE SUITE 800 SEATTLE WA 98121
Business Address 3101 WESTERN AVENUE SUITE 800 SEATTLE WA 98121 2062827100
CTI BIOPHARMA CORP (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-28386 | Film No.: 21751618
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences